An adult (age 18 or older) with clinical and radiographic evidence of community-acquired pneumonia who tests positive for influenza virus. This specific co-occurrence has distinct management implications beyond standard CAP care alone.
A confirmed influenza test in a patient with radiographically proven CAP triggers a dual-component treatment strategy. Guidelines specify that the antiinfluenza component should be started regardless of how long symptoms have been present before the diagnosis is made — a clinically important point that differs from general antiviral guidance.
Current evidence supports initiating both standard antibacterial therapy for CAP and antiinfluenza treatment together — the antiviral component applies irrespective of illness duration at diagnosis. The complete protocol covers agent selection, sequencing, and the full clinical decision path.
Full regimen details, drug selection, and algorithm are available in the structured protocol below.
DOI: 10.1164/rccm.201908-1581ST
We recommend that antiinfluenza treatment, such as oseltamivir, be prescribed for adults with CAP who test positive for influenza in the inpatient setting, independent of duration of illness before diagnosis (strong recommendation, moderate quality of evidence).
We recommend that standard antibacterial treatment be initially prescribed for adults with clinical and radiographic evidence of CAP who test positive for influenza in the inpatient and outpatient settings (strong recommendation, low quality of evidence).
View source ↗